Allspring Global Investments’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.5M Sell
608,826
-9,773
-2% -$981K 0.09% 256
2025
Q4
$62.9M Sell
618,599
-12,256
-2% -$1.1M 0.1% 236
2025
Q3
$39.5M Buy
+630,855
New +$34.3M 0.06% 355
2024
Q2
Sell
-13,250
Closed -$273K 2436
2024
Q1
$273K Buy
+13,250
New +$284K ﹤0.01% 1645
2023
Q4
Sell
-3,864
Closed -$115K 2425
2023
Q3
$115K Buy
+3,864
New +$136K ﹤0.01% 1945
2022
Q1
Sell
-13
Closed -$1K 3032
2021
Q4
$1K Buy
+13
New +$1.34K ﹤0.01% 2939

Other funds holding GH

Allspring Global Investments's GH Position: Q1 2026 in Review

Allspring Global Investments reduced its Guardant Health (GH) stake by 1.6% in Q1 2026, selling an estimated $981K and leaving 608,826 shares worth $55.5M. The position accounts for 0.09% of the portfolio, ranked #256.

Allspring Global Investments first reported a position in GH in Q4 2021 and has held it in 6 quarters since. The position peaked at $62.9M in Q4 2025. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Allspring Global Investments held 608,826 shares of Guardant Health worth $55.5M as of Q1 2026.
  • Allspring Global Investments sold 9,773 Guardant Health shares in Q1 2026, an estimated $981K.
  • Guardant Health made up 0.09% of Allspring Global Investments's portfolio in Q1 2026, its #256 holding.
  • Allspring Global Investments first reported a position in Guardant Health in Q4 2021 and has held it in 6 quarters since.
  • Allspring Global Investments's Guardant Health position peaked at $62.9M in Q4 2025.
  • 483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.